3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Adenomatous Polyposis Coli
1
Interventions
durvalumab
7
Gemcitabine
7
Oxaliplatin
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
Cisplatin
6
Specimen Handling
5
Fluorouracil
5
Biopsy
5
Paclitaxel
4
Folfox protocol
4
Irinotecan
3
pemigatinib
2
pembrolizumab
2
olaparib
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Taxes
2
Nivolumab
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Disulfides
2
Carboplatin
2
zimberelimab
1
zanidatamab
1
ulixertinib
1
tremelimumab
1
trametinib
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
trifluridine tipiracil drug combination
×
30 days
×
Clear all
No trials found.